What are the effects of cabergoline on breastfeeding for the next baby?

Cabergoline, as a dopamine receptor agonist, is widely used in the treatment of hyperprolactinemia, breast cancer, Parkinson's disease and other diseases. However, some side effects and potential risks during its use, especially the impact on lactating women and future breastfeeding, have attracted much attention.

The metabolism and excretion of cabergoline in the body may affect breast milk quality. Although the drug is metabolized out of the body over time, if used during pregnancy or breastfeeding, drug residues may pass into the baby's milk, posing a potential threat to his or her health. The extent and duration of this threat depend on a variety of factors, such as the dose and duration of medication, as well as individual differences.

Infants exposed to cabergoline through breast milk may experience a range of adverse reactions. These reactions may include but are not limited to nausea, vomiting, diarrhea, rash, etc. In severe cases, they may even affect the baby's growth, development and nervous system function. Although there are no conclusive studies proving that cabergoline causes long-term or serious harm to nursing infants, any potential risks should not be ignored.

Because of the possible effects of cabergoline on milk quality and infant health, doctors often recommend suspending breastfeeding while taking the drug. Specifically, you need to wait for a period of time after stopping the drug (such as 7 days to 12 days) to ensure that the drug is completely metabolized out of the body before starting breastfeeding. Doing this minimizes the risk of the baby being exposed to the medicine.

For breastfeeding women who plan to use cabergoline, be sure to consult a professional physician before using cabergoline and learn more about the side effects and potential risks of the drug. Use the medication strictly according to the doctor's instructions and do not adjust the dosage or medication time by yourself. Suspend breastfeeding while taking this medication and monitor the baby's health closely. If you have any concerns or discomfort, seek medical advice promptly and inform your doctor of your medication status.